Insider Selling: LivaNova PLC (LIVN) Director Sells 1,000 Shares of Stock

LivaNova PLC (NASDAQ:LIVN) Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $116.68, for a total value of $116,680.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Daniel Jeffrey Moore also recently made the following trade(s):

  • On Monday, October 15th, Daniel Jeffrey Moore sold 1,000 shares of LivaNova stock. The stock was sold at an average price of $113.30, for a total value of $113,300.00.
  • On Monday, September 17th, Daniel Jeffrey Moore sold 1,000 shares of LivaNova stock. The stock was sold at an average price of $123.49, for a total value of $123,490.00.

Shares of NASDAQ:LIVN traded down $5.49 during trading on Monday, reaching $119.93. 23,302 shares of the company traded hands, compared to its average volume of 537,738. The firm has a market cap of $6.11 billion, a PE ratio of 36.35, a price-to-earnings-growth ratio of 3.77 and a beta of 0.94. LivaNova PLC has a 52-week low of $76.14 and a 52-week high of $131.54. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.65.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, October 31st. The company reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.08). The company had revenue of $272.10 million for the quarter, compared to analysts’ expectations of $275.03 million. LivaNova had a negative net margin of 8.31% and a positive return on equity of 8.77%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period last year, the company posted $0.83 EPS. Research analysts predict that LivaNova PLC will post 3.1 EPS for the current year.

LIVN has been the subject of several research reports. BidaskClub raised LivaNova from a “buy” rating to a “strong-buy” rating in a research note on Thursday, July 26th. Needham & Company LLC reissued a “buy” rating and set a $135.00 price objective (up previously from $128.00) on shares of LivaNova in a research note on Wednesday, August 1st. BTIG Research reissued a “hold” rating on shares of LivaNova in a research note on Thursday, November 1st. Stifel Nicolaus increased their price objective on LivaNova from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, September 17th. Finally, Zacks Investment Research lowered LivaNova from a “buy” rating to a “hold” rating in a research note on Thursday, September 20th. Three analysts have rated the stock with a hold rating, three have given a buy rating and two have assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $126.50.

Several institutional investors have recently made changes to their positions in the stock. Cubist Systematic Strategies LLC raised its holdings in shares of LivaNova by 22.2% during the second quarter. Cubist Systematic Strategies LLC now owns 2,404 shares of the company’s stock valued at $240,000 after acquiring an additional 437 shares in the last quarter. Crossmark Global Holdings Inc. raised its holdings in shares of LivaNova by 6.8% during the second quarter. Crossmark Global Holdings Inc. now owns 7,410 shares of the company’s stock valued at $740,000 after acquiring an additional 470 shares in the last quarter. Oregon Public Employees Retirement Fund raised its holdings in shares of LivaNova by 3.0% during the second quarter. Oregon Public Employees Retirement Fund now owns 17,026 shares of the company’s stock valued at $1,700,000 after acquiring an additional 490 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of LivaNova by 2.0% during the second quarter. Russell Investments Group Ltd. now owns 24,904 shares of the company’s stock valued at $2,487,000 after acquiring an additional 497 shares in the last quarter. Finally, Securian Asset Management Inc raised its holdings in shares of LivaNova by 9.4% during the third quarter. Securian Asset Management Inc now owns 5,950 shares of the company’s stock valued at $738,000 after acquiring an additional 510 shares in the last quarter. Institutional investors own 82.26% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2018/11/19/insider-selling-livanova-plc-livn-director-sells-1000-shares-of-stock.html.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates in two segments, Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories for extracorporeal circulation, and systems for autotransfusion and autologous blood washing, as well as surgical tissue and mechanical heart valve replacements, and repair products for damaged or diseased heart valves.

Featured Article: What is the yield curve?

Insider Buying and Selling by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply